RMMS Scores Win in Case Involving DUEXIS® tablets (800 mg ibuprofen and 26.6 mg famotidine) 11/30/2020
RMMS Again Recognized as Litigation Leader in IAM Patent 1000 – Firm Partners Receive Individual Recognition 06/11/2020
RMMS Secures Favorable Resolution in BPCIA Litigation Involving FULPHILA® (pegfilgrastim-jmdb) 11/01/2019
